At this stage, ECFCs have already been diluted/replaced by endothelial cells sprouting from neighbouring capillaries and B-TEC mainly derive from VEGF-sensitive cancer stem cells or adjoining sprouting capillaries [12, 74–76]. This evidence concerns the gene VEGFA and cancer.